VS

VCJ Staff

Nutanix Inks $13.2M Series A

4 min read · 19 April 2011

Circassia Inks $98M For Biopharma

Oxford-based Circassia Ltd. has closed on 60 million pounds ($98 million) in new financing, bringing the total raised by the company to $159 million. The company, a specialty biopharmaceutical company focused on allergy treatments, will pull the money down in two tranches over the next two years. The money will fund phase three development of Circassia's cat and ragweed allergy therapies. Imperial Innovations led the round, which included investments from existing shareholders including Invesco Perpetual.

3 min read · 19 April 2011

Digby Inks $8M Series C

Austin-based mobile commerce start-up Digby has raised $8 million in Series C financing. Battery Ventures led the round, which included funding from BlackBerry Partners Fund, S3 Ventures and Daylight Partners. Digby focuses on mobile commerce products for retailers, and will use the money to bolster sales, marketing, research and platform development.

5 min read · 18 April 2011

SEP Leads $28.4M Investment in Media Ingenuity

Growth capital and venture investment firm Scottish Equity Partners has led a 17.5 million pound ($28.4 million) investment in UK-based online marketing technology company Media Ingenuity, earning a minority stake. The money will help Media Ingenuity with growth, and continued development.

2 min read · 18 April 2011

CoDa Therapeutics Inks $19.2M Series B

San Diego-based CoDa Therapeutics Inc. has raised $19.2 million in a first closing of Series B financing. Existing shareholders Domain Associates, GBS Venture Partners and BioPacificVentures participated in the round. CoDa is a clinical-stage biopharmaceutical company working to develop drug therapies for wounds that do not heal properly, including venous leg and diabetic foot ulcers. The company will use the Series B financing for continued development.

4 min read · 18 April 2011

Symphony Technology Group Buys ImpactRx

Private equity firm Symphony Technology Partners has acquired a majority stake in ImpactRx, a developer of a subscription database for pharmaceutical companies. The company, based in Mr. Laurel, N.J., had recently closed a $1.2 million Series E round in January, and was backed by roughly $36 million from investors including Mediphase Venture Partners, 3i Group, Oxford Bioscience Partners and Merck Capital Ventures. Financial terms of the acquisition by Symphony Technology Group were not released.

3 min read · 18 April 2011

Metaforic Inks $8M Round Led by SEP

Growth equity and venture firm Scottish Equity Partners led a 5 million pound ($8 million) investment in Metaforic, a software start-up based in Glasgow, Scottland, and California. The company is developing security software to combat piracy and hacker attacks. Pentech Ventures and the Scottish Investment Bank's Scottish Venture Fund also contributed to the round, which will help the company expand sales and marketing.

3 min read · 18 April 2011

SilverRail Technologies Adds $5M Infusion

SilverRail Technologies, maker of a platform for passenger rail ticketing, has inked $5 million in new financing. The company, which is based in Boston and London, is backed by PAR Capital, Sutter Hill, Grandbanks Capital, Brook Ventures and Accel Partners. PAR Capital led the most recent round, which will help the company expand its platform and integrate with new rail carrier inventory systems.

2 min read · 18 April 2011

Concur Pours $40M into Cleartrip

Publicly traded Concur Technologies Inc. said it would pay $40 million for a minority stake in Indian online travel site Cleartrip. The start-up has previously raised at least $18 million from venture investors including Draper Fisher Jurvetson, The Mahindra Group, Sherpalo Ventures and Kleiner Perkins Caufield & Byers. The investment with Concur Technologies includes includes a marketing partnership through which Concur's products will help Cleartrip's clients generate travel and expense reports, Reuters reported.

1 min read · 18 April 2011

Lymbix Inks $1.35M From GrowthWorks

GrowthWorks Atlantic Venture Fund has poured $1.34 million in Lymbix Inc., a Moncton, New Brunswick-based developer of technology designed to help people and organizations be understood clearly. The company describes its flagship software, ToneCheck, as an “emotional spell-check”. GrowthWorks is a Canadian investment firm.

3 min read · 18 April 2011

Showing 3,601 to 3,610 of 12,105 results
1…360362…1000